Assistant Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Amy Y. Lin, MD
|
|
Give Review
Dr. Amy Y. Lin is an expert in the field of Internal Medicine. She graduated from University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification". has written publications. She has 28 publications published with PubMed. The lastest paper is: 'Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Can...' Dr. Amy Y. Lin is registered with Medicare and accepts Medicare payments.
Publications
- Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Can...
- Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulatin...
- Intestinal tumor suppression in Apc(Min/+) mice by prostaglandin D2 receptor PTGDR.
- A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate ...
- Hematopoietic prostaglandin D synthase (HPGDS): A high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.
- A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.
- Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequences.
- Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resist...
- Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screening.
- Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.
- Prostate cancer update: 2007.
- Management of hormone refractory prostate cancer.
- A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
- Prostate cancer update: 2006.
- Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells.
- Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.
- Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
- Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.
- Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.
- Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
- The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
- Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.
- A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
- Clinical trials in patients with biochemically relapsed prostate cancer.
- A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy.
- Intermittent chemotherapy for metastatic hormone refractory prostate cancer.
Schools
Johns Hopkins University School of Medicine
Greater Baltimore Med Center
University Of Illinois At Chicago Med Center
University Of Illinois Eye and Ear Infirmary
Conditions Treated
- Fuchs' Corneal Dystrophy
- Keratitis
- Retinal Detachment and Retinal Tear
Doctors Specialties
- Ophthalmology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
New York Presbyterian Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
UCSF Medical Center -
San Francisco VA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Robert I. Slott, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark K. Kosinski, DO |
|
|
Dr. Pompilia C. Tudoriu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael C. Giovingo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randy P. Orr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veena V. Arun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yi Jiang, MD |
|
|
Dr. Albert P. Knott Jr., MD
This Doctor is OpenDoctor Recommended.
|